Outlook Therapeutics OTLK
NASDAQ OTLK
$0.56 +0.04 (+7.94%)
At close: Oct 21, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Raw Materials (2025 - 2026)

Updated

Outlook Therapeutics (OTLK) recorded Raw Materials of $2.34 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Raw Materials (2025 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics reported Raw Materials of $2.35 million.

  • Quarterly Raw Materials has ranged from $2.34 million in fiscal Q2 2026 to $2.35 million in fiscal Q1 2026 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at $2.34 million (Q2 2026), $2.35 million (Q1 2026) and $2.35 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Outlook Therapeutics 77.51 Mn 41.76 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.34 Mn
Mar 31, 2026 2.34 Mn
Dec 31, 2025 2.35 Mn
Sep 30, 2025 2.35 Mn
API Access

Outlook Therapeutics Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=OTLK&period=max&api_key=YOUR_API_KEY